TAURX
LIVE

Serial Number

79183545

Owner

TauRx Therapeutics Ltd.

Attorney

Thad Chaloemtiarana

Filing Date

Dec 22, 2015

Add to watchlist:

No watchlists yet
View on USPTO

TAURX Trademark

Serial Number: 79183545 • Registration: 5135047

TAURX is a trademark filed by TauRx Therapeutics Ltd. on December 22, 2015. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

TauRx Therapeutics Ltd.

25 Bukit Batok Crescent,

Entity Type: 99

Trademark Details

Filing Date

December 22, 2015

Registration Date

February 7, 2017

Published for Opposition

November 22, 2016

Goods & Services

Medical clinic services; health resort services in the nature of medical clinics; services for the provision of medical facilities; medical services; medical advisory services; medical diagnostic testing, monitoring and reporting services; providing medical information, consultancy and advisory services; medical screening information services featuring reminder alerts regarding medical examinations that individuals should undergo for preventative care purposes; medical screening services in the fields of neurodegenerative and neurological diseases and disorders, malaria and infectious diseases; medical services featuring health assessment surveys; consultancy and information services relating to all the aforesaid

Medical, biological, biotechnological, genetic, and pharmaceutical research, design and development services and laboratory research services in the fields of drugs, pharmaceuticals and medicines; research, development and design of drugs and medicine; drug discovery services; laboratory and medical laboratory research and development services relating to drugs, pharmaceuticals and medicines; exploitation of scientific research and technology, namely, providing advice and information relating to scientific and technological research, researching and developing new products in the fields of drugs, pharmaceuticals and medicines, and scientific research and development services in the fields of drug development, clinical trial design, patient recruitment, drug testing, clinical data management, data analysis, statistical analysis, patient selection, clinical diagnosis and diagnostic testing; preparation of reports of scientific and medical research concerning drugs, pharmaceuticals, medicines, genetics, biology and biotechnology; development and design of medical or scientific prognostic and diagnostic apparatus and instruments; consultancy and information services relating to all of the aforesaid

Retail store services and online retail store services in connection with the sale of pharmaceutical and medical preparations, chemical preparations for medical and pharmaceutical purposes, surgical and medical apparatus and instruments, apparatus for carrying out tests for medical purposes, scientific and medical apparatus for use in tests; consulting services in the field of medical practice management for others in the fields of neurodegenerative and neurological diseases and disorders, malaria and infectious diseases

Pharmaceutical and medical preparations for use in relation to neurological diseases and disorders, neurodegenerative diseases and disorders, blood disorders, infectious diseases and malaria; chemical preparations for medical and pharmaceutical purposes for use in relation to neurological diseases and disorders, neurodegenerative diseases and disorders, blood disorders, infectious diseases and malaria; none of the aforesaid being pharmaceutical preparations and substances intended for the prevention and treatment of bone/skeletal diseases

Surgical and medical apparatus and instruments for use in general surgery; medical apparatus and instruments for facilitating the analysis of biological and chemical matter in the field of genetic testing, namely, blood, brain, urine, cerebrospinal fluid analysis and testing apparatus; medical testing apparatus for the analysis of biological and chemical matter, namely, apparatus for blood, brain, urine and cerebrospinal fluid analysis and tests; surgical and medical apparatus and instruments for facilitating the analysis of biological and chemical matter, namely, apparatus for blood, brain, urine and cerebrospinal fluid analysis and tests

Filing History

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Feb 7, 2026 REM4
INTERNATIONAL REGISTRATION RENEWED
Jan 22, 2026 RNWL
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Dec 8, 2023 NA71
REGISTERED-SEC.71 ACCEPTED
Dec 8, 2023 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 21, 2023 APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 15, 2023 APRE
TEAS SECTION 71 RECEIVED
Mar 22, 2023 ES71
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 10, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 10, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 10, 2022 REAP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Feb 7, 2022 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 16, 2017 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 26, 2017 FICS
FINAL DISPOSITION PROCESSED
May 26, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 7, 2017 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 7, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 22, 2016 NPUB
PUBLISHED FOR OPPOSITION
Nov 22, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 2, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 7, 2016 CNSA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 5, 2016 GNRN
NON-FINAL ACTION E-MAILED
Oct 5, 2016 GNRT
NON-FINAL ACTION WRITTEN
Oct 5, 2016 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 8, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 8, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 8, 2016 TROA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Sep 8, 2016 ZZZX
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 6, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 2, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 2, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 2, 2016 TROA
REFUSAL PROCESSED BY IB
May 14, 2016 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 19, 2016 RFCS
REFUSAL PROCESSED BY MPU
Apr 19, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 16, 2016 RFCR
NON-FINAL ACTION WRITTEN
Apr 15, 2016 CNRT
ASSIGNED TO EXAMINER
Apr 11, 2016 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 4, 2016 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 29, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 25, 2016 REPR